Literature DB >> 9176087

Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.

C Homann1, K Varming, K Høgåsen, T E Mollnes, N Graudal, A C Thomsen, P Garred.   

Abstract

BACKGROUND: Acquired deficiencies of certain complement proteins and impaired opsonisation activity have been implicated in the pathogenesis of the increased susceptibility to infections of patients with alcoholic cirrhosis.
METHODS: Serum concentrations of C3 and C4, plasma concentrations of C3bc, C9, and the terminal C5b-9 complement complex (TCC), and haemolytic complement activity (classic and alternative pathway) of serum, and serum opsonic activity were determined in 46 patients with compensated alcoholic cirrhosis, 31 who were decompensated, and in 15 healthy subjects. After 19 months (median) the investigated variables were analysed for their use in prognosis of recurrent infections and survival.
RESULTS: C3 and C4 concentrations and the haemolytic complement activity of the alternative pathway were decreased in decompensated cirrhotic patients compared with controls (p < 0.01). Univariate analysis (log rank test) showed that low concentrations (< or = lower quartile) of C3 (p < 0.001) and C3bc (p < 0.05), haemolytic complement activity of the alternative pathway (p < 0.01) and classic pathway (p < 0.05), and decompensated cirrhosis (p < 0.001) were associated with an increased risk of infection and increased mortality. Multivariate (Cox) analysis showed that low C3 concentrations and decompensation of cirrhosis were significant predictors of infections and mortality (p < 0.02).
CONCLUSIONS: Low serum C3 concentrations and decreased haemolytic complement function predisposes to infection and increased mortality in patients with alcoholic cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176087      PMCID: PMC1027133          DOI: 10.1136/gut.40.4.544

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis.

Authors:  J Such; C Guarner; J Enriquez; J L Rodriguez; I Seres; F Vilardell
Journal:  J Hepatol       Date:  1988-02       Impact factor: 25.083

2.  Multivariate survival analysis using Cox's regression model.

Authors:  E Christensen
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

3.  Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis.

Authors:  A B Lumsden; J M Henderson; M H Kutner
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

4.  Mannan-binding protein and complement dependent opsonization in alcoholic cirrhosis.

Authors:  C Homann; P Garred; P Hasselqvist; N Graudal; S Thiel; A C Thomsen
Journal:  Liver       Date:  1995-02

5.  Plasma calprotectin: a new prognostic marker of survival in alcohol-induced cirrhosis.

Authors:  C Homann; P Garred; N Graudal; P Hasselqvist; M Christiansen; M K Fagerhol; A C Thomsen
Journal:  Hepatology       Date:  1995-04       Impact factor: 17.425

6.  Chemoattractant and opsonic activity in ascitic fluid. A study in 47 patients with cirrhosis or malignant peritonitis.

Authors:  F Mal; T P Huu; M Bendahou; J C Trinchet; M Garnier; J Hakim; M Beaugrand
Journal:  J Hepatol       Date:  1991-01       Impact factor: 25.083

7.  Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis.

Authors:  B A Runyon
Journal:  Hepatology       Date:  1988 May-Jun       Impact factor: 17.425

8.  Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Authors:  M Andreu; R Sola; A Sitges-Serra; C Alia; M Gallen; M C Vila; S Coll; M I Oliver
Journal:  Gastroenterology       Date:  1993-04       Impact factor: 22.682

9.  Complement levels in patients with hepatic dysfunction.

Authors:  R T Ellison; C R Horsburgh; J Curd
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

10.  Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC).

Authors:  T E Mollnes; H Redl; K Høgåsen; A Bengtsson; P Garred; L Speilberg; T Lea; M Oppermann; O Götze; G Schlag
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

View more
  35 in total

1.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 2.  Hepcidin: the missing link between hemochromatosis and infections.

Authors:  Houman Ashrafian
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

3.  Vitamin D status and expression of vitamin D receptor and LL-37 in patients with spontaneous bacterial peritonitis.

Authors:  Chong Zhang; Lianrong Zhao; Li Ma; Cheng Lv; Yang Ding; Tingting Xia; Jingyan Wang; Xiaoguang Dou
Journal:  Dig Dis Sci       Date:  2011-07-14       Impact factor: 3.199

4.  Increased risk and case fatality rate of pyogenic liver abscess in patients with liver cirrhosis: a nationwide study in Denmark.

Authors:  I Mølle; A M Thulstrup; H Vilstrup; H T Sørensen
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Role of Pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats.

Authors:  R B Alcantara; L C Preheim; M J Gentry
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 6.  Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding.

Authors:  Yeong Yeh Lee; Hoi-Poh Tee; Sanjiv Mahadeva
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  Liver cirrhosis as a real risk factor for necrotising fasciitis: a three-year population-based follow-up study.

Authors:  Tsung-Hsing Hung; Chen-Chi Tsai; Chih-Chun Tsai; Chih-Wei Tseng; Yu-Hsi Hsieh
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858

8.  Clinical characteristics and risk factors for nosocomial candidemia in medical intensive care units: experience in a single hospital in Korea for 6.6 years.

Authors:  Seon-Sook Han; Jae-Joon Yim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Sang-Min Lee
Journal:  J Korean Med Sci       Date:  2010-04-16       Impact factor: 2.153

9.  Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.

Authors:  Hangeun Kim; Keith Meyer; Adrian M Di Bisceglie; Ranjit Ray
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

Review 10.  Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids.

Authors:  Ikuo Nakamura
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.